T&L Co., Ltd. (KOSDAQ:340570)

South Korea · Delayed Price · Currency is KRW

50,300

-2,100 (-4.01%)

Jul 20, 2026, 3:30 PM KST

-16.72% (1Y)

Market Cap	403.26B -16.6%
Revenue (ttm)	157.91B -21.6%
Net Income	38.66B -29.9%
EPS	4,806.55 -29.7%
Shares Out	8.02M
PE Ratio	10.46
Forward PE	6.50
Dividend	1,500.00 (2.86%)
Ex-Dividend Date	Dec 29, 2025

Volume	25,893
Open	52,100
Previous Close	52,400
Day's Range	49,900 - 52,100
52-Week Range	43,100 - 68,000
Beta	0.37
Analysts	Strong Buy
Price Target	89,000.00 (+76.94%)
Earnings Date	Aug 14, 2026

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea. [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1998

Employees 242

Stock Exchange KOSDAQ

Ticker Symbol 340570

Full Company Profile

Financial Performance

In 2025, T&L Co., Ltd.'s revenue was 164.16 billion, a decrease of -6.14% compared to the previous year's 174.89 billion. Earnings were 38.07 billion, a decrease of -17.96%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 340570 stock is "Strong Buy." The 12-month stock price target is ₩89,000, which is an increase of 76.94% from the latest price.

Price Target

₩89,000

(76.94% upside)

Analyst Consensus: Strong Buy

Stock Forecasts